EUVIMEDEUVIMED entdecken
Crossref

Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery

Mohammed Hamouda, Shima Rahgozar, Umu-Hawa Rogers, Dong-Jin E Kang Sim, Matthew Smeds, Mahmoud B Malas

Journal of Vascular Surgery · 2026-08 · 84 (2) · 510-518

DOI: 10.1016/j.jvs.2026.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2026-08. Verfasst von Mohammed Hamouda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Peripheral Arterial Disease, Blood Vessel Prosthesis Implantation. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Peripheral arterial disease (PAD) is highly prevalent among patients requiring hemodialysis access and reflects advanced systemic atherosclerosis. We evaluated whether PAD severity is associated with increased postoperative complications and loss of primary patency following dialysis access creation and performed stratified analyses by access type: arteriovenous fistula (AVF) and arteriovenous graft (AVG). METHODS We used the Vascular Quality Initiative database from 2011 to 2024, including patients undergoing upper-extremity hemodialysis access creation. PAD status was categorized as no PAD, asymptomatic PAD, claudication, or chronic limb-threatening ischemia (CLTI). Postoperative outcomes included 30-day mortality, prolonged length of stay, bleeding, thrombosis, and steal syndrome. Six-month primary patency was defined as time to first intervention, thrombosis, failure, or abandonment. Multivariable logistic and Cox regression analyses were performed in the overall cohort, followed by subgroup analyses stratified by AVF and AVG. RESULTS A total of 78,607 patients were included (25,718 [32.7%] no PAD; 47,771 [60.8%] asymptomatic PAD; 2079 [2.6%] claudication; and 3039 [3.9%] CLTI). In the overall cohort, increasing PAD severity was independently associated with worse postoperative outcomes. Compared with patients without PAD, asymptomatic PAD (adjusted odds ratio [aOR] 1.55; 95% confidence interval [CI], 1.27-1.90; P < .001), claudication (aOR 2.20; 95% CI, 1.52-3.18; P < .001), and CLTI (aOR 3.01; 95% CI, 2.24-4.06; P < .001) were associated with progressively higher odds of 30-day mortality. Asymptomatic PAD (aOR 1.41; 95% CI, 1.16-1.71; P < .001) and CLTI (aOR 2.27; 95% CI, 1.82-2.83; P < .001) were associated with prolonged length of stay. Asymptomatic PAD was also associated with increased odds of postoperative bleeding (aOR 1.30; 95% CI, 1.01-1.69; P = .043). Claudication (aOR 3.57; 95% CI, 1.33-9.59; P = .012) and CLTI (aOR 2.87; 95% CI, 1.21-6.82; P = .017) were associated with increased odds of steal syndrome, whereas PAD severity was not associated with postoperative thrombosis. At 6 months, all PAD stages were strongly associated with loss of primary patency: asymptomatic PAD (adjusted hazard ratio [aHR] 5.09; 95% CI, 3.15-8.22; P < .001), claudication (aHR 4.79; 95% CI, 2.86-8.02; P < .001), and CLTI (aHR 5.05; 95% CI, 3.14-8.10; P < .001). Findings were consistent in analyses stratified by AVF and AVG. CONCLUSIONS To our knowledge, this is the first study to comprehensively evaluate the impact of PAD and PAD progression on outcomes and patency of dialysis access. PAD severity is independently associated with increased postoperative complications, 30-day mortality, and loss of primary patency following dialysis access creation. Notably, even asymptomatic PAD confers significantly increased risk of mortality and loss of primary patency at 6 months. These findings highlight the importance of incorporating PAD status into preoperative risk stratification and dialysis access planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisArteriovenous Shunt, SurgicalPeripheral Arterial DiseaseBlood Vessel Prosthesis ImplantationPostoperative ComplicationsHumansFemaleMaleRisk FactorsVascular PatencyAgedTime FactorsRisk AssessmentTreatment OutcomeDisease ProgressionDatabases, FactualSeverity of Illness IndexMiddle AgedRetrospective StudiesGraft Occlusion, VascularIntermittent Claudication

Stichwörter der Autor:innen

Arteriovenous fistulaArteriovenous graftChronic limb-threatening ischemiaClaudicationDialysis accessPeripheral arterial disease

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Saint Louis University, Saint Louis, MO.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, UC San Diego, La Jolla, CA. Electronic address: mmalas@ucsd.edu.

Zitieren

APA

Hamouda, M., Rahgozar, S., Rogers, U. H., Kang Sim, D. E., Smeds, M., & Malas, M. B. (2026). Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery. Journal of Vascular Surgery, 84(2), 510-518. https://doi.org/10.1016/j.jvs.2026.04.007

Vancouver

Hamouda M, Rahgozar S, Rogers UH, Kang Sim DE, Smeds M, Malas MB. Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery. Journal of Vascular Surgery. 2026;84(2):510-518. doi:10.1016/j.jvs.2026.04.007

BibTeX
@article{Hamouda2026,
  author = {Hamouda, Mohammed and Rahgozar, Shima and Rogers, Umu-Hawa and Kang Sim, Dong-Jin E and Smeds, Matthew and Malas, Mahmoud B},
  title = {Progression of peripheral arterial disease predicts worse outcomes after dialysis access surgery},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  volume = {84},
  number = {2},
  pages = {510--518},
  doi = {10.1016/j.jvs.2026.04.007}
}
Kostenlos starten →